Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-kB signaling improves the efficacy of immunotherapy in a brain cancer model

Title

Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-kB signaling improves the efficacy of immunotherapy in a brain cancer model

Creator

MineharuY, Muhammad AG, Yagiz K, Candolfi M, Kroeger KM, Xiong W, Puntel M, Lui C, Levy E, Lugo C, Kocharian A, Allison J, Curran M, Lowenstein PR, and Castro MG.

Subject

Science, Research, Gene Therapy

Language

English

Type

Article

Identifier

PMCID: PMC3480576

Citation

MineharuY, Muhammad AG, Yagiz K, Candolfi M, Kroeger KM, Xiong W, Puntel M, Lui C, Levy E, Lugo C, Kocharian A, Allison J, Curran M, Lowenstein PR, and Castro MG., “Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-kB signaling improves the efficacy of immunotherapy in a brain cancer model,” CEW Online Library, accessed December 1, 2022, https://cewlib.omeka.net/items/show/4632.